Pure Global

Clinical Trial - Trial ChiCTR-IOR-15006941

Access comprehensive clinical trial information for ChiCTR-IOR-15006941 through Pure Global AI's free database. This phase not specified trial is sponsored by The second people's hospital of Shenzhen and is currently Recruiting. The study focuses on Type 2 Diabetes mellitus.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Chinese Clinical Trial Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
ChiCTR-IOR-15006941
Recruiting
Trial Details
Chinese Clinical Trial Registry โ€ข ChiCTR-IOR-15006941
View on Chinese Clinical Trial Registry
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Untitled Trial
Comparative Study on the Influence on Blood Glucose Fluctuation of DPP-4 Inhibitor or Acarbose for T2DM Patients with Inadequately Controlled with insulin

Study Focus

Type 2 Diabetes mellitus

Sponsor & Location

The second people's hospital of Shenzhen

self-financing

China

Timeline & Enrollment

N/A

N/A

Oct 01, 2016

ICD-10 Classifications

Type 2 diabetes mellitus
Type 2 diabetes mellitus with unspecified complications
Type 2 diabetes mellitus with other specified complications
Type 2 diabetes mellitus without complications
Type 2 diabetes mellitus with multiple complications

Data Source

Chinese Clinical Trial Registry

ChiCTR-IOR-15006941

Non-Device Trial